References
- Sewell EC, Proano RA, Jacobson SH, Jokela JA. S tockpile levels for pediatric vaccines: how much is enough? Vaccine 24, 3530–3537 (2006).
- Centers for Disease Control and Prevention. Recommended Childhood Immunization Schedule-United States 2010. Morb. Mortal Wkly Rep.61(05), 1–4 (2012).
- Robbins MJ, Jacobson SH, Sewell EC. Pricing strategies for combination pediatric vaccines and their impact on revenue: Pediarix or Pentacel? Health Care Manag. Sci. 13(1), 54–64 (2010).
- Coleman MS, Sangrujee N, Zhou F, Chu S. Factors affecting U.S. manufacturers’ decisions to produce vaccines. Health Aff. (Millwood) 24(3), 635–642 (2005).
- Sewell EC, Jacobson SH, Karnani T. An integer programming model for vaccine procurement and delivery for childhood immunization: a pilot study. Health Care Manag. Sci. 2, 1–9 (1999).
- Chen RT, Jacobson SH, Sewell EC, et al. Addressing the challenges to immunization practice with an economic algorithm for vaccine selection. Vaccine 164, 1885–1897 (1998).
- Sewell EC, Deuson R, Jacobson SH, Weniger BG. Engineering the economic value of two pediatric combination vaccines. Health Care Manag. Sci. 8(1), 29–40 (2005).
- Robbins MJ, Jacobson SH. The altruistic monopsonist vaccine formulary pricing and purchasing problem: informing public health policy. Omega 39(6), 589–597 (2011).
- Cowan AE, Gregory S, Clark SJ, Freed GL. Variation in provider vaccine purchase pricesand payer reimbursement. Pediatrics 124(Suppl. 5) S459–S465 (2009).
- Sewell EC, Jacobson SH. Using an integer programming model to determine the price of combination vaccines for childhood immunization. Ann Oper. Res. 119, 261–284 (2003).
- Sewell EC, Jacobson SH, Weniger BG. ‘Reverse engineering’ a formulary selection algorithm to determine the economic value of pentavalent and hexavalent combination vaccines. Pediatr. Infect. Dis. J. 20(Suppl. 11), S45–S56 (2001).
- Centers for Disease Control and Prevention. Combination vaccines for childhood immunization, Recommendations of the Advisory Committee on Immunization Practices (ACIP), American Academy of Pediatrics (AAP), and American Academy of Family Physicians (AAFP). Morb. Mortal Wkly Rep. 48(RR-4), 1–15 (1999).
- Centers for Disease Control and Prevention. Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine and guidance for use as a booster dose. Morb. Mortal Wkly Rep.57(39), 1078–1079 (2008).
- Centers for Disease Control and Prevention. Updated recommendations for use of Haemophilus influenzae type B (Hib) vaccine: reinstatement of the booster dose at ages 12–15 months. Morb. Mortal Wkly Rep. 58(24), 673–674 (2009).
- Centers for Disease Control and Prevention. Interim recommendations for the use of Haemophilus influenzae type B (Hib) conjugate vaccines related to the recall of certain lots of Hib containing vaccines (Pedvaxhib and Comvax). Morb. Mortal Wkly Rep. 56(50), 1318–1320(2007).
Websites
- Centers for Disease Control and Prevention. Vaccine price list (contract ending 31 March 2010).www.cdc.gov/vaccines/programs/vfc/downloads/archived- pricelists/2010/12162010.htm(Accessed 5 October 2011)
- Centers for Disease Control and Prevention. Vaccine price list (contract ending 31 March 2011).www.cdc.gov/vaccines/programs/vfc/downloads/archived- pricelists/2010/12162010.htm(Accessed 5 October 2011)
- Centers for Disease Control and Prevention. Vaccine price list (contract ending 31 March 2012). www.cdc.gov/vaccines/programs/vfc/downloads/archived-pricelists/2011/09292011.htm(Accessed 5 October 2011)
- Food and Drug Administration. Vaccines licensed for immunization and distribution in the United States.www.fda.gov/cber/vaccine/licvacc.htm(Accessed 6 October 2011)
- Centers for Disease Control and Prevention. Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed and in- activated poliovirus vaccine and guidance for use as a booster dose.www.cdc.gov/mmwr/preview/mmwrhtml/mm5739a4.htm(Accessed 10 January 2012)
- Inc. Merck & Co. Voluntary recall of certain lots of pedvaxhib and comvax.www.merckvaccines.com/PCHRecall.pdf(Accessed 20 January, 2012)